33 related articles for article (PubMed ID: 8679806)
1. Efficacy and safety of intravenous valproate for status epilepticus: a systematic review.
Trinka E; Höfler J; Zerbs A; Brigo F
CNS Drugs; 2014 Jul; 28(7):623-39. PubMed ID: 24806973
[TBL] [Abstract][Full Text] [Related]
2. Intravenous sodium valproate versus diazepam infusion for the control of refractory status epilepticus in children: a randomized controlled trial.
Mehta V; Singhi P; Singhi S
J Child Neurol; 2007 Oct; 22(10):1191-7. PubMed ID: 17940245
[TBL] [Abstract][Full Text] [Related]
3. Fatal fulminant hepatic failure due to sodium valproate in an adolescent.
Puri AS; Sharma BC; Khan EM; Saraswat VA
Indian Pediatr; 1994 Feb; 31(2):207-10. PubMed ID: 7875849
[No Abstract] [Full Text] [Related]
4. Efficacy of rapid IV administration of valproic acid for status epilepticus.
Rossetti AO; Bromfield EB
Neurology; 2005 Aug; 65(3):500-1; author reply 500-1. PubMed ID: 16087935
[No Abstract] [Full Text] [Related]
5. A suspected case of late-onset sodium-valproate-induced hepatic failure.
van Egmond H; Degomme P; de Simpel H; Dierick AM; Roels H
Neuropediatrics; 1987 May; 18(2):96-8. PubMed ID: 3110642
[TBL] [Abstract][Full Text] [Related]
6. [Irreversible valproate-associated liver failure].
Siemes H; Nau H; Seidel U; Gramm HJ
Monatsschr Kinderheilkd; 1992 Dec; 140(12):869-75. PubMed ID: 1491708
[TBL] [Abstract][Full Text] [Related]
7. [Hemorrhagic shock and fulminant hepatic failure associated with valproate].
Fernandez-Fernandez FJ; Garcia-Rego J; Garcia-Jimenez A; Sesma P
An Med Interna; 1995 Dec; 12(12):606-8. PubMed ID: 8679806
[TBL] [Abstract][Full Text] [Related]
8. Fulminant hepatic failure associated with status epilepticus in children: three cases and a review of potential mechanisms.
Decell MK; Gordon JB; Silver K; Meagher-Villemure K
Intensive Care Med; 1994 May; 20(5):375-8. PubMed ID: 7930035
[TBL] [Abstract][Full Text] [Related]
9. Valproate-induced hyperammonemic encephalopathy.
Segura-Bruna N; Rodriguez-Campello A; Puente V; Roquer J
Acta Neurol Scand; 2006 Jul; 114(1):1-7. PubMed ID: 16774619
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy and safety of intravenous valproates].
Kholin AA; Voronkova KV; Pylaeva OA; Petrukhin AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(3 Suppl 2):55-9. PubMed ID: 20873475
[No Abstract] [Full Text] [Related]
11. Valproate-induced hyperammonemic encephalopathy: a brief review.
Lewis C; Deshpande A; Tesar GE; Dale R
Curr Med Res Opin; 2012 Jun; 28(6):1039-42. PubMed ID: 22587482
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of rapid IV administration of valproic acid for status epilepticus.
Limdi NA; Shimpi AV; Faught E; Gomez CR; Burneo JG
Neurology; 2005 Jan; 64(2):353-5. PubMed ID: 15668440
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
